SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-092662
Filing Date
2023-12-04
Accepted
2023-12-04 16:01:10
Documents
14
Period of Report
2023-11-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea189363-8k_bimiinter.htm   iXBRL 8-K 30877
2 EXHIBIT 16.1 ea189363ex16-1_bimiinter.htm EX-16.1 2088
6 GRAPHIC image_001.jpg GRAPHIC 91562
  Complete submission text file 0001213900-23-092662.txt   335409

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bimi-20231129.xsd EX-101.SCH 3009
4 XBRL LABEL FILE bimi-20231129_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bimi-20231129_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT ea189363-8k_bimiinter_htm.xml XML 3411
Mailing Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK
Business Address 725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK NY NEW YORK 212-542-0028
BIMI International Medical Inc. (Filer) CIK: 0001213660 (see all company filings)

IRS No.: 020563302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34890 | Film No.: 231462926
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries